{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:25:59Z","timestamp":1793676359557,"version":"4.5.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Accurate recognition of high-grade dysplasia (HGD) and early invasive carcinoma (IC) within colorectal polyps is essential for selecting the preferred local resection technique. However, optical endoscopic diagnosis can be challenging, particularly in large and advanced polyps. This study investigates whether carcinoembryonic antigen (CEA)-targeted near-infrared fluorescence (NIRF) imaging can distinguish polyps containing HGD\/IC from polyps solely containing low-grade dysplasia (LGD), given prior evidence of CEA overexpression in HGD\/IC relative to LGD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients scheduled for local en-bloc endoscopic resection of advanced rectal polyps were included in the study and received 5\u00a0mg or 10\u00a0mg intravenous SGM-101, a CEA-targeted fluorescent agent. In vivo imaging was performed using a rigid Quest-Olympus NIRF-endoscope, followed by ex vivo whole-specimen and bread-loaf imaging using the PEARL imaging system. The primary endpoint was the NIRF tumour-to-low-grade-dysplasia ratio (TDR; HGD\/IC divided by LGD) performed on bread loafs, as this method enabled direct pathological correlation. Secondary endpoints included dose-finding as well as sensitivity and specificity for detecting HGD\/IC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 22 patients were included, with 9\/22 containing LGD only and 13\/22 containing HGD\/IC. Eleven patients received 10\u00a0mg and 11 received 5\u00a0mg SGM-101. Ex vivo bread-loaf imaging showed a median (IQR) TDR of 1.7 (1.3\u20132.9), with higher values in the 10\u00a0mg group of 2.5 (2.0-3.5) compared to the 1.3 (1.2\u20131.6) in the 5\u00a0mg group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.023). The sensitivity for detecting HGD\/IC was 86% (2 false-negatives), and specificity was 88% (1 false-positive).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although with limited sample size, this study demonstrates proof-of-concept of CEA-targeted NIRF-imaging in differentiating HGD\/IC bearing polyps from completely benign LGD polyps. Clinical utility, including its impact on treatment decision-making and patient outcomes, remains to be demonstrated in future, larger prospective studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration number<\/jats:title>\n                    <jats:p>NCT06280690.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00259-026-08155-z","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:03:10Z","timestamp":1788418990000},"page":"8463-8477","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CEA-targeted fluorescence endoscopy for the detection of high-grade dysplasia and early invasive rectal cancer: A proof-of-concept trial"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4546-5966","authenticated-orcid":false,"given":"M. I.","family":"Warmerdam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. H.","family":"Dijkhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J. G.","family":"Linders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. M. W.","family":"Pesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S. L. P.","family":"Crobach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Matoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Basiliya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. H.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cailler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. C. M. J.","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. A.","family":"Holman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. S. D.","family":"Mieog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. L.","family":"Vahrmeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. E.","family":"Hilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Boonstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"8155_CR1","unstructured":"Nederlandse Kankerregistratie, Stadium bij diagnose \u2013 Verdeling in 2023. 2023; Available from: https:\/\/iknl.nl\/kankersoorten\/darmkanker\/cijfers."},{"key":"8155_CR2","unstructured":"RIVM-Landelijke monitor bevolkingsonderzoek darmkanker. 2023. Available from: file:\/\/vf-lumc-home.lumcnet.prod.intern\/lumc-home$\/miwarmerdam1\/Roaming\/Downloads\/Monitor-BVO-DK-2023%20(1).pdf."},{"issue":"1","key":"8155_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-019-01485-z","volume":"25","author":"Y Hashiguchi","year":"2020","unstructured":"Hashiguchi Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25(1):1\u201342.","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"8155_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1136\/gutjnl-2016-313101","volume":"67","author":"RM Barendse","year":"2018","unstructured":"Barendse RM, et al. Randomised controlled trial of transanal endoscopic microsurgery versus endoscopic mucosal resection for large rectal adenomas (TREND Study). Gut. 2018;67(5):837\u201346.","journal-title":"Gut"},{"issue":"10","key":"8155_CR5","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1002\/bjs.11590","volume":"107","author":"R Detering","year":"2020","unstructured":"Detering R, et al. MRI cT1-2 rectal cancer staging accuracy: a population-based study. Br J Surg. 2020;107(10):1372\u201382.","journal-title":"Br J Surg"},{"issue":"2","key":"8155_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1136\/gutjnl-2017-314723","volume":"68","author":"Y Backes","year":"2019","unstructured":"Backes Y, et al. Multicentre prospective evaluation of real-time optical diagnosis of T1 colorectal cancer in large non-pedunculated colorectal polyps using narrow band imaging (the OPTICAL study). Gut. 2019;68(2):271\u20139.","journal-title":"Gut"},{"issue":"11","key":"8155_CR7","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1136\/gutjnl-2019-320403","volume":"69","author":"LWT Meulen","year":"2020","unstructured":"Meulen LWT, et al. Optical diagnosis of T1 CRCs and treatment consequences in the Dutch CRC screening programme. Gut. 2020;69(11):2049\u201351.","journal-title":"Gut"},{"issue":"2","key":"8155_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.gie.2019.04.217","volume":"90","author":"BPH Chan","year":"2019","unstructured":"Chan BPH, et al. EUS versus magnetic resonance imaging in staging rectal adenocarcinoma: a diagnostic test accuracy meta-analysis. Gastrointest Endosc. 2019;90(2):196\u2013e2031.","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"8155_CR9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ajg.2017.58","volume":"112","author":"Y Backes","year":"2017","unstructured":"Backes Y, et al. Risk for Incomplete Resection after Macroscopic Radical Endoscopic Resection of T1 Colorectal Cancer: A Multicenter Cohort Study. Am J Gastroenterol. 2017;112(5):785\u201396.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"8155_CR10","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1055\/s-0032-1325686","volume":"44","author":"B Rembacken","year":"2012","unstructured":"Rembacken B, et al. Quality in screening colonoscopy: position statement of the European Society of Gastrointestinal Endoscopy (ESGE). Endoscopy. 2012;44(10):957\u201368.","journal-title":"Endoscopy"},{"issue":"5","key":"8155_CR11","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1053\/j.gastro.2018.01.003","volume":"154","author":"AF Peery","year":"2018","unstructured":"Peery AF, et al. Increasing Rates of Surgery for Patients With Nonmalignant Colorectal Polyps in the United States. Gastroenterology. 2018;154(5):1352\u2013e13603.","journal-title":"Gastroenterology"},{"issue":"1","key":"8155_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-021-00548-3","volume":"19","author":"JSD Mieog","year":"2022","unstructured":"Mieog JSD, et al. Fundamentals and developments in fluorescence-guided cancer surgery. Nat Rev Clin Oncol. 2022;19(1):9\u201322.","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"8155_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrclinonc.2013.123","volume":"10","author":"AL Vahrmeijer","year":"2013","unstructured":"Vahrmeijer AL, et al. Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol. 2013;10(9):507\u201318.","journal-title":"Nat Rev Clin Oncol"},{"key":"8155_CR14","unstructured":"Dekkers N et al. Immunohistochemical markers for fluorescence-guided endoscopy in advanced colorectal polyps Under submission, 2022."},{"key":"8155_CR15","unstructured":"van Eijck RAH, et al. Short-term outcomes of endoscopic submucosal dissection for suspected T1 colorectal cancers: a European experience. Gastrointest Endosc. 2025."},{"issue":"3","key":"8155_CR16","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1245\/s10434-020-09069-2","volume":"28","author":"KS de Valk","year":"2021","unstructured":"de Valk KS, et al. Dose-Finding Study of a CEA-Targeting Agent, SGM-101, for Intraoperative Fluorescence Imaging of Colorectal Cancer. Ann Surg Oncol. 2021;28(3):1832\u201344.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"8155_CR17","doi-asserted-by":"publisher","DOI":"10.1117\/1.JBO.29.2.026001","volume":"29","author":"TH Dijkhuis","year":"2024","unstructured":"Dijkhuis TH, et al. Semi-automatic standardized analysis method to objectively evaluate near-infrared fluorescent dyes in image-guided surgery. J Biomed Opt. 2024;29(2):026001.","journal-title":"J Biomed Opt"},{"key":"8155_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13000-014-0221-9","volume":"9","author":"N Fedchenko","year":"2014","unstructured":"Fedchenko N, Reifenrath J. Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue - a review. Diagn Pathol. 2014;9:221.","journal-title":"Diagn Pathol"},{"issue":"3","key":"8155_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S2468-1253(17)30395-3","volume":"3","author":"LSF Boogerd","year":"2018","unstructured":"Boogerd LSF, et al. Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study. Lancet Gastroenterol Hepatol. 2018;3(3):181\u201391.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"8155_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/bjs\/znaa004","volume":"108","author":"RA Cahill","year":"2021","unstructured":"Cahill RA, et al. Artificial intelligence indocyanine green (ICG) perfusion for colorectal cancer intra-operative tissue classification. Br J Surg. 2021;108(1):5\u20139.","journal-title":"Br J Surg"},{"issue":"8","key":"8155_CR21","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/nm.3641","volume":"21","author":"J Burggraaf","year":"2015","unstructured":"Burggraaf J, et al. Detection of colorectal polyps in humans using an intravenously administered fluorescent peptide targeted against c-Met. Nat Med. 2015;21(8):955\u201361.","journal-title":"Nat Med"},{"issue":"3","key":"8155_CR22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1136\/gutjnl-2019-319755","volume":"69","author":"JJJ Tjalma","year":"2020","unstructured":"Tjalma JJJ, et al. Quantitative fluorescence endoscopy: an innovative endoscopy approach to evaluate neoadjuvant treatment response in locally advanced rectal cancer. Gut. 2020;69(3):406\u201310.","journal-title":"Gut"},{"issue":"1","key":"8155_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-34855-9","volume":"13","author":"AF Aldilaijan","year":"2023","unstructured":"Aldilaijan AF, et al. Clinical implication of tissue carcinoembryonic antigen expression in association with serum carcinoembryonic antigen in colorectal cancer. Sci Rep. 2023;13(1):7616.","journal-title":"Sci Rep"},{"key":"8155_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107464","volume":"209","author":"DGJ Linders","year":"2024","unstructured":"Linders DGJ, et al. Ex vivo fluorescence-guided resection margin assessment in breast cancer surgery using a topically applied, cathepsin-activatable imaging agent. Pharmacol Res. 2024;209:107464.","journal-title":"Pharmacol Res"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08155-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-08155-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08155-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:29:43Z","timestamp":1793672983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-08155-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":24,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["8155"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-08155-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"4 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Medical Ethics Review Committee Leiden-Den Haag-Delft (METC LDD), Leiden, The Netherlands, on 23 August 2023 (Reference study number P23.020). The study was registered at ClinicalTrials.gov (NCT06280690). The study was conducted in accordance with the Declaration of Helsinki, Good Clinical Practice (ICH-GCP) guidelines, and applicable Dutch laws and regulations governing medical research involving human subjects.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All authors have read this manuscript and would like to have it considered exclusively for publication.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"F. Cailler is employed by SurgiMab, which owns the SGM-101 conjugate. F. Cailler is part of the SurgiMab founders and is stockholder. All other authors declare no competing interests.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Ethics"}}]}}